Leadership Overview
Johnson & Johnson Services Inc has 10 executives leading key functions including strategy, financial oversight, information technology, procurement, and clinical services.
Focused on advancing global healthcare, Johnson & Johnson Services Inc delivers innovative pharmaceuticals and medical technologies to improve patient outcomes across oncology, immunology, and neuroscience sectors worldwide.
Focused on advancing global healthcare, Johnson & Johnson Services Inc delivers innovative pharmaceuticals and medical technologies to improve patient outcomes across oncology, immunology, and neuroscience sectors worldwide.
Leadership Roles at Johnson & Johnson Services Inc
Joaquin Duato - Chief Executive Officer
Joaquin Duato, the Chief Executive Officer at Johnson & Johnson Services Inc, directs the overarching corporate strategy for this global healthcare leader. Overseeing the integration of pharmaceutical research and medical device innovation, the Chief Executive Officer ensures alignment with long-term growth objectives. This leadership role involves managing complex international operations while maintaining rigorous standards in oncology and immunology development. By fostering collaboration across diverse business units, Duato drives the company toward sustainable market expansion. The Chief Executive Officer maintains constant communication with the Board to refine operational priorities and address evolving healthcare needs. Through disciplined capital allocation and a focus on transformative medical technologies, Joaquin Duato secures the competitive position of the organization. Ultimately, Duato champions a culture of scientific excellence that benefits patients and healthcare providers across all global markets.
Dominic Caruso - Chief Financial Officer
Dominic Caruso, the Chief Financial Officer at Johnson & Johnson Services Inc, manages the enterprise-wide financial architecture and fiscal health. Overseeing global reporting, the Chief Financial Officer ensures transparency and compliance across all pharmaceutical and medical device divisions. This leadership role involves optimizing capital structures to support research and development initiatives in neuroscience and cardiovascular care. By analyzing market trends, Caruso provides the strategic insights necessary for informed investment decisions. The Chief Financial Officer coordinates with regional finance teams to maintain robust internal controls and risk management frameworks. Through precise financial planning, Dominic Caruso supports the company's ability to deliver innovative medicines to patients worldwide. Ultimately, Caruso maintains the fiscal integrity required to sustain the long-term mission of the organization within the competitive global healthcare landscape.
Michael Boennighausen - Chief Financial Officer & Principal Accounting Officer & Vice President, Administration & Finance
Michael Boennighausen, the Chief Financial Officer & Principal Accounting Officer & Vice President, Administration & Finance at Johnson & Johnson Services Inc, directs the administrative and accounting functions of the corporation. Overseeing internal financial reporting, the Chief Financial Officer & Principal Accounting Officer & Vice President, Administration & Finance ensures the accuracy of all fiscal disclosures. This leadership role involves streamlining administrative processes to enhance operational efficiency across the global medical technology portfolio. By managing complex accounting standards, Boennighausen supports the integrity of the company's financial statements. The Chief Financial Officer & Principal Accounting Officer & Vice President, Administration & Finance collaborates with executive leadership to align administrative resources with strategic business goals. Through rigorous oversight of financial systems, Michael Boennighausen facilitates the stable growth of the organization. Ultimately, Boennighausen ensures that administrative operations support the delivery of high-quality healthcare solutions.
Salvatore Giovine - Chief Financial Officer & Vice President, Finance, Innovative Medicine (North America)
Salvatore Giovine, the Chief Financial Officer & Vice President, Finance, Innovative Medicine (North America) at Johnson & Johnson Services Inc, manages the financial performance of the innovative medicine division within the North American market. Overseeing regional budget allocation, the Chief Financial Officer & Vice President, Finance, Innovative Medicine (North America) ensures that resources support the development of advanced pharmaceutical therapies. This leadership role involves analyzing regional market dynamics to maximize the impact of oncology and immunology product launches. By coordinating with commercial teams, Giovine drives financial efficiency in the delivery of medical solutions to healthcare providers. The Chief Financial Officer & Vice President, Finance, Innovative Medicine (North America) monitors regional economic indicators to mitigate risks and capitalize on growth opportunities. Through strategic financial management, Salvatore Giovine strengthens the company's market presence. Ultimately, Giovine supports the regional execution of the broader corporate mission.
Ketaki Mahajan - Chief Financial Officer & VP, Corporate Operations, IT & Global Finance Talent Development
Ketaki Mahajan, the Chief Financial Officer & VP, Corporate Operations, IT & Global Finance Talent Development at Johnson & Johnson Services Inc, manages the intersection of corporate operations and financial talent strategy. Overseeing the development of global finance teams, the Chief Financial Officer & VP, Corporate Operations, IT & Global Finance Talent Development ensures that the organization possesses the human capital necessary to support complex financial operations. This leadership role involves optimizing IT-related financial processes to improve operational efficiency. By fostering talent growth, Mahajan strengthens the company's ability to manage fiscal responsibilities across diverse international markets. The Chief Financial Officer & VP, Corporate Operations, IT & Global Finance Talent Development collaborates with leadership to align operational investments with corporate goals. Through strategic talent management, Ketaki Mahajan supports the long-term financial health of the organization. Ultimately, Mahajan ensures that operational and financial functions remain synchronized.
Jonathan Loane - Chief Financial Officer & Vice President, Finance, Global Medical Devices Supply Chain
Jonathan Loane, the Chief Financial Officer & Vice President, Finance, Global Medical Devices Supply Chain at Johnson & Johnson Services Inc, directs the financial strategy for the global medical devices supply chain. Overseeing the fiscal health of logistics and manufacturing operations, the Chief Financial Officer & Vice President, Finance, Global Medical Devices Supply Chain ensures that resources are allocated to maintain a resilient supply network. This leadership role involves analyzing cost structures to improve the profitability of surgical products and medical devices. By coordinating with global supply chain leaders, Loane supports the efficient distribution of medical technologies to healthcare providers. The Chief Financial Officer & Vice President, Finance, Global Medical Devices Supply Chain monitors financial performance metrics to drive operational improvements. Through strategic financial oversight, Jonathan Loane strengthens the company's supply chain capabilities. Ultimately, Loane ensures that financial management supports the global availability of essential medical devices.
James Swanson - Chief Information Officer & Executive Vice President
James Swanson, the Chief Information Officer & Executive Vice President at Johnson & Johnson Services Inc, directs the digital transformation and technological infrastructure of the enterprise. Overseeing global data systems, the Chief Information Officer & Executive Vice President ensures that advanced analytics support the development of pharmaceuticals and medical devices. This leadership role involves architecting secure platforms that facilitate research in neuroscience and cardiovascular care. By integrating emerging technologies, Swanson enhances operational agility across all business units. The Chief Information Officer & Executive Vice President collaborates with other C-suite leaders to align digital capabilities with long-term strategic objectives. Through the implementation of scalable IT solutions, James Swanson drives innovation in patient care delivery. Ultimately, Swanson ensures that the technological foundation of the company remains robust, secure, and capable of supporting the complex needs of a global healthcare leader.
Diandra Hayban - Global Director, Procurement & Chief Revenue Officer, Functional & Clinical Services
Diandra Hayban, the Global Director, Procurement & Chief Revenue Officer, Functional & Clinical Services at Johnson & Johnson Services Inc, directs the procurement strategy and revenue generation for clinical service lines. Overseeing the supply chain for functional services, the Global Director, Procurement & Chief Revenue Officer, Functional & Clinical Services ensures that clinical operations receive the necessary resources to maintain high standards. This leadership role involves negotiating strategic partnerships to optimize the delivery of medical services. By focusing on revenue growth within clinical segments, Hayban supports the overall financial performance of the company. The Global Director, Procurement & Chief Revenue Officer, Functional & Clinical Services coordinates with cross-functional teams to ensure that procurement activities align with patient care requirements. Through efficient management of clinical service resources, Diandra Hayban drives value across the organization. Ultimately, Hayban ensures that procurement and revenue strategies support the company's commitment to medical excellence.
Keith McKune - Senior Scientist & Chief Revenue Officer, Analytical (Release & Stability )
Keith McKune, the Senior Scientist & Chief Revenue Officer, Analytical (Release & Stability ) at Johnson & Johnson Services Inc, directs the analytical processes required for product release and stability testing. Overseeing the scientific validation of pharmaceuticals, the Senior Scientist & Chief Revenue Officer, Analytical (Release & Stability ) ensures that all products meet rigorous quality standards before reaching patients. This leadership role involves managing the revenue impact of analytical efficiency and product throughput. By applying scientific expertise to stability testing, McKune supports the reliability of the company's medical portfolio. The Senior Scientist & Chief Revenue Officer, Analytical (Release & Stability ) collaborates with quality assurance teams to maintain compliance and operational excellence. Through the optimization of analytical workflows, Keith McKune facilitates the timely delivery of innovative medicines. Ultimately, McKune ensures that scientific rigor remains a cornerstone of the company's revenue-generating activities.
Nina Martinez - Category Director, Innovative Medicine Procurement, Functional Chief Revenue Officer and Clinical Services
Nina Martinez, the Category Director, Innovative Medicine Procurement, Functional Chief Revenue Officer and Clinical Services at Johnson & Johnson Services Inc, manages the procurement categories for innovative medicine and oversees revenue streams related to clinical services. Overseeing the sourcing of critical materials, the Category Director, Innovative Medicine Procurement, Functional Chief Revenue Officer and Clinical Services ensures that the pharmaceutical pipeline remains well-supplied. This leadership role involves driving revenue growth through the strategic management of clinical service offerings. By aligning procurement activities with clinical needs, Martinez supports the efficient development of new medical technologies. The Category Director, Innovative Medicine Procurement, Functional Chief Revenue Officer and Clinical Services collaborates with internal stakeholders to optimize the value chain. Through precise category management, Nina Martinez enhances the company's ability to deliver life-saving treatments. Ultimately, Martinez ensures that procurement and clinical revenue strategies remain integrated and effective.
Explore Leadership Teams in Manufacturing
Founded in 2005, Headquartered in Tokyo, Daiichi Sankyo is a global pharmaceutical company that develops and provides innovative new and generic medicines, as well as advanced drug discovery and delivery methods, serving patients in over 30 countries.
Company Leadership CB
BL
KM
KI
PCI Pharma Services is an integrated full service provider to companies in the global healthcare industry. They offer services including analytical services, formulation development, clinical trial supply, commercial manufacturing and packaging, QP services, supply chain management, storage, and distribution. They are headquartered in Philadelphia, Pennsylvania with locations in the United States and Europe.
Company Leadership BP
HL
BK
Emcure Pharmaceuticals Limited is a global pharmaceutical company engaged in the research, development, manufacturing, and marketing of a broad range of pharmaceutical products and healthcare solutions. Headquartered in Pune, India, the organization operates as an international pharmaceutical enterprise with a strong presence in both domestic and global healthcare markets. The company focuses on delivering innovative and affordable medicines that address a wide spectrum of medical conditions and therapeutic needs across the healthcare sector. The organization is driven by a research-focused strategy that emphasizes innovation, scientific advancement, and the development of effective therapeutic solutions. Through its research and development capabilities, Emcure Pharmaceuticals works to discover and formulate medicines that address unmet medical needs and improve patient outcomes. The company’s research initiatives focus on areas such as complex generics, biosimilars, biologics, and specialized pharmaceutical formulations. These research efforts allow the organization to continuously introduce improved therapies and drug delivery systems designed to enhance treatment effectiveness and patient safety.
Company Leadership SM
SM
TS
Shionogi & Co., Ltd. is a Japanese pharmaceutical company dedicated to developing innovative treatments that improve patient lives worldwide. With a longstanding focus on addressing pressing global health challenges, the company has been a pioneer in discovering and delivering novel therapies for infectious diseases, including antibiotics, HIV, influenza, and emerging viral threats such as COVID-19. Shionogi combines in-house research and development with strategic collaborations across industry, government agencies, biotech companies, and academic institutions to accelerate the advancement of its scientific programs and bring meaningful therapies to patients with urgency and precision.
Company Leadership TK
AD
TN
Frequently Asked Questions Regarding Johnson & Johnson Services Inc Top Executives and Leadership Team
